Accueil>>Analytical Standards>>2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride) (exempt preparation)

2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride) (exempt preparation) (Synonyms: TMCPF)

Catalog No.GC91579

2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride) (exempt preparation) is an analytical reference standard categorized as an opioid.

Products are for research use only. Not for human use. We do not sell to patients.

2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride) (exempt preparation) Chemical Structure

Cas No.: 2309383-12-6

Taille Prix Stock Qté
100 µg
133,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride) (exempt preparation) is an analytical reference standard categorized as an opioid.[1] 2,2,3,3-tetramethyl-Cyclopropyl fentanyl is regulated as a Schedule I compound in the United States. 2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride) (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

References:
[1].Eshleman, A.J., Nagarajan, S., Wolfrum, K.M., et al.Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptorsBiochem. Pharmacol.182114293(2020).

Avis

Review for 2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride) (exempt preparation)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 2,2,3,3-tetramethyl-Cyclopropyl fentanyl (hydrochloride) (exempt preparation)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.